The importance of treating the field in actinic keratosis
Author:
- 6 March 2017
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 31 (S2) , 8-11
Abstract
Actinic keratoses (AKs) are intraepithelial atypical proliferations of keratinocytes that develop in skin that has undergone long‐term exposure to ultraviolet radiation. Given the ageing population and an increasing prevalence of AK, the socio‐economic burden of AK is likely to rise over the coming years. Areas of subclinical (non‐visible) sun damage in the periphery of visible AK lesions contain the same genetic changes as those found in the lesions themselves, and are known as areas of field cancerization. AK lesions and the field are associated with an increased risk of skin cancer, including invasive squamous cell carcinoma. Although effective in clearing visible AK, lesion‐directed therapies do not address field cancerization and can lead to high recurrence rates. In contrast, field‐directed therapies, such as ingenol mebutate, imiquimod and diclofenac, can clear both visible and subclinical AK lesions and reduce the development of new lesions in the treated field. Additionally, preclinical studies suggest that field therapy may prevent or delay the recurrence of non‐melanoma skin cancer. AK treatment guidelines now recognize the importance of treating the field in patients with AK, and adaptation of treatment guidelines into clinical practice is warranted. Physician and patient education around the consequences of leaving the field of cancerization untreated is necessary in order to reduce the increasing burden associated with AK.Keywords
This publication has 34 references indexed in Scilit:
- Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012Journal of the American Academy of Dermatology, 2013
- The importance of early diagnosis and treatment of actinic keratosisJournal of the American Academy of Dermatology, 2013
- Pharmacotherapy of actinic keratosis: an updateExpert Opinion on Pharmacotherapy, 2012
- Actinic keratosis in theen-faceand slice imaging mode of high-definition optical coherence tomography and comparison with histologyBritish Journal of Dermatology, 2012
- Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 PatchesJournal of Investigative Dermatology, 2012
- Current and emerging treatment strategies for the treatment of actinic keratosisClinical, Cosmetic and Investigational Dermatology, 2010
- Reflectance Confocal Microscopy for Noninvasive Monitoring of Therapy and Detection of Subclinical Actinic KeratosesDermatology, 2009
- A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-upBritish Journal of Dermatology, 2007
- A prospective study of the use of cryosurgery for the treatment of actinic keratosesInternational Journal of Dermatology, 2004
- The Majority of Cutaneous Squamous Cell Carcinomas Arise in Actinic KeratosesJournal of Cutaneous Medicine and Surgery, 2002